600488 津药药业
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资28,4980.26%28,42413,61422,31721,965
投资性房地产0--0000
固定资产2,552,803-2.21%2,610,5992,830,1913,034,6123,047,057
在建工程24,014-63.50%65,79144,52034,440126,707
无形资产375,520-3.36%388,592349,664303,658254,605
商誉0--0000
其他非流动资产515,3749.62%470,132655,838639,387839,876
3,496,210-1.89%3,563,5383,893,8274,034,4144,290,210

流动资产
货币资金856,2903.84%824,598638,456718,856647,742
应收账款591,6649.91%538,327291,238429,951342,135
存货592,2411.44%583,836651,915725,5811,157,531
其他流动资产213,080-14.56%249,393222,849233,680213,081
2,253,2762.60%2,196,1541,804,4592,108,0682,360,490

流动负债
短期借款108,067-35.63%167,875108,576270,253648,338
应付票据147,81764.13%90,059109,80738,560165,778
应付帐款544,20612.16%485,219528,886680,992627,123
其他流动负债800,24588.69%424,097467,726950,495838,861
1,600,33537.10%1,167,2491,214,9961,940,2992,280,100
流动资产净值652,941-36.54%1,028,905589,463167,76980,389
资产总额减流动负债4,149,151-9.65%4,592,4434,483,2914,202,1834,370,600

非流动负债
长期借款124,263-76.78%535,110424,600277,000458,640
应付债券0--0000
其他非流动负债180,45910.99%162,589172,827171,879158,122
304,722-56.32%697,698597,427448,879616,762

总权益
    实收股本1,091,8870.00%1,091,8871,091,8871,093,9331,096,363
    储备项目1,931,882-0.54%1,942,4501,965,4601,859,6221,876,146
股东权益3,023,769-0.35%3,034,3373,057,3472,953,5542,972,508
非控股权益820,660-4.62%860,408828,517799,750781,329